The National Women’s Law Center has joined various amicus briefs, alongside reproductive health, rights, and justice organizations, as well as other organizations with a strong interest in access to reproductive care, in support of the Biden Administration’s appeal of Judge Kascmaryk’s decision in Alliance for Hippocratic Medicine, et al., v. U.S. Food & Drug Administration, et al. This unprecedented and dangerous decision would overturn the Food and Drug Administration’s expertise and nearly 25-year-old approval of mifepristone, one of the medications in a two-drug protocol that is now used in over half of the abortions in this country. As these briefs explained, mifepristone is safe, effective, widely used, and has been critical to filling the gaps in abortion care for the most underserved communities. These briefs also debunked false assertions about mifepristone and its safety record that Judge Kascmaryk relied on in his decision. These briefs further explained how suspending the FDA’s approval of the drug would have immediate and severe consequences to the administrative process and our systems of democracy.
- On May 1, 2023, NWLC joined over 200 organizations in filing an amicus brief in the U.S. Court of Appeals for the Fifth Circuit supporting the Biden Administration’s appeal of Judge Kascmaryk’s decision staying the FDA’s approval of Mifepristone from over two decades ago, blocking access to mifepristone nationwide.
- On April 14, 2023, NWLC joined over 200 organizations in filing an amicus brief in the Supreme Court supporting the Biden Administration’s appeal of the Fifth Circuit’s decision partially upholding Judge Kacsmaryk’s preliminary injunction. This decision would have severely restricted access to mifepristone nationwide.
- On April 11, 2023, NWLC joined over 150 organizations in filing an amicus brief in the U.S. Court of Appeals for the Fifth Circuit supporting the Biden Administration’s appeal of Judge Kascmaryk’s decision to grant a preliminary injunction, banning nationwide access to mifepristone while the case makes its way through the court.